Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Moonlake Immunotherapeutics

Moonlake Immunotherapeutics (MLTX)

Market is closed
Latest 13D & 13G Filings
Company Symbol Filed By Filing Date Filing
Moonlake Immunotherapeutics
MLTX
Cormorant Asset Management
 2026-08-14
13G Filing
Moonlake Immunotherapeutics
MLTX
 T. Rowe Price Investment Management, Inc. 2026-08-14
13G Filing
Moonlake Immunotherapeutics
MLTX
Deep Track Capital
 2026-08-14
13G Filing
Moonlake Immunotherapeutics
MLTX
 BIOTECHNOLOGY VALUE FUND L P 2026-06-29
13D Filing
Moonlake Immunotherapeutics
MLTX
Cormorant Asset Management
 2026-05-15
13G Filing
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.